Serum KL-6 as a possible marker for amiodarone-induced pulmonary toxicity

Citation
M. Nakajima et al., Serum KL-6 as a possible marker for amiodarone-induced pulmonary toxicity, INTERN MED, 39(12), 2000, pp. 1097-1100
Citations number
13
Categorie Soggetti
General & Internal Medicine
Journal title
INTERNAL MEDICINE
ISSN journal
09182918 → ACNP
Volume
39
Issue
12
Year of publication
2000
Pages
1097 - 1100
Database
ISI
SICI code
0918-2918(200012)39:12<1097:SKAAPM>2.0.ZU;2-S
Abstract
Amiodarone is a useful drug for the treatment of life-threatening cardiac a rrhythmias, However, amiodarone can induced pulmonary toxicity (APT) and ma y cause life-threatening lung damage. APT can be difficult to diagnose, but early diagnosis is important. Here, in a 51-year-old man with APT, the hig h serum KL-6 level was correlated with the severity of symptoms and chest X -ray findings, and it was inversely correlated with PaO2 and diffusion capa city for carbon monoxide levels. The findings suggest that the serum KL-6 l evel may be increased in APT and that therefore it's the determination of s erum KL-6 may provide a useful indicator and/or monitoring marker of APT. K L-6 is believed to be produced and secreted by type II pneumocytes, Typical pathological findings of APT include proliferation of type II pneumocytes which may produce KL-6, and result in increased serum KL-6 levels.